EdgarLookup
SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company
CytomX Therapeutics, Inc.
Filed
July 29, 2022
Accession Number
0000921895-22-002304
View Document ↗ View on SEC.gov ↗